What is Envoy Medical's stock issuance proceeds?

Envoy Medical (COCH) reported stock issuance proceeds of $30M in Q1 2026.

What does stock issuance proceeds mean?

Cash inflows generated from the sale of new common equity shares to investors. This represents a primary method for raising capital to fund operations, acquisitions, or debt repayment. High levels of issuance may indicate growth initiatives but can also lead to shareholder dilution.

Envoy Medical COCH Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

ePlusPLUS

$1.85M+1.4%

BCB BancorpBCBP

$250K-46.9%

RGC ResourcesRGCO

$1.04M+135%

Lexicon PharmaceuticalsLXRX

$69.99M—

New Horizon AircraftHOVR

$3.95M—

WhirlpoolWHR

$524M—

Other financials

Income statement

See full

Revenue$39.0K-15.2%

Gross profit-$274.0K-52.2%

Operating income-$6.0M-16.7%

Net income-$4.4M+12.9%

EPS (diluted)-$0.08+72.4%

Balance sheet

See full

Cash & equivalents$25.3M+376%

Total debt$919.0K-2.8%

Total equity$10.2M+142%

Total assets$29.8M+187%

Cash flow

See full

Operating cash flow-$6.1M-62.7%

CapEx$172.0K—

Free cash flow-$5.9M-28.5%

Valuation

See full

Market cap$61M+83.5%

P/S260.7×+111×

Profitability

See full

Gross margin-310.7%+31.6pp

Operating margin-9,881.2%+805pp

Net margin-9,875.6%+771pp

FCF margin-7,626.6%-652pp

Returns & leverage

See full

Return on equity328.7%—

Debt / equity0.1×—

Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Envoy Medical's stock issuance proceeds?: Envoy Medical (COCH) reported stock issuance proceeds of $30M in Q1 2026.
What does stock issuance proceeds mean?: Cash inflows generated from the sale of new common equity shares to investors. This represents a primary method for raising capital to fund operations, acquisitions, or debt repayment. High levels of issuance may indicate growth initiatives but can also lead to shareholder dilution.